XVIVO Perfusion appoints Lena Hagman as deputy CEO

MARKN.

The Board of Directors of XVIVO Perfusion AB (publ) (“XVIVO”) has today appointed Lena Hagman as deputy CEO. She will remain in her role as COO.

Lena Hagman has been a member of XVIVO’s management team since December 2022 and has a long career in the medical technology industry, with more than 20 years of global experience in leading positions with responsibility in R&D, supply chain and quality regulatory/medical affairs. Prior to joining XVIVO, Lena Hagman has held several leading roles in Swedish and global medical technology companies.

November 14, 2024
Mölndal, Sweden

The Board of Directors
XVIVO Perfusion AB (publ)

Datum 2024-11-14, kl 16:00
Källa MFN
Alla Aktier tipsar: Har du redan ett konto på Avanza? Varför inte skapa ett på Nordnet också och jämföra funktioner, courtage mm. Det tar inte lång tid, du fixar det direkt här med BankID
Investeringar i värdepapper och fonder innebär alltid en risk och det är inte säkert att du får tillbaka det investerade kapitalet